February 4, 2025
Rosenau Family Research Foundation (RFRF) would like to extend its congratulations to its 2025 class of grant recipients.
The mission and vision of RFRF is improving the lives of patients impacted by Krabbe disease and Cystic Fibrosis through research funding and disease advocacy, and helping individuals live life undefined by Krabbe disease and Cystic Fibrosis.
To support this mission and vision, the foundation considers grant funding for basic science research, translational research, and clinical research that can lead to or enhance treatments and cures for Krabbe disease and Cystic Fibrosis. Programs that promote, through education and awareness, the expansion of Newborn Screening, Krabbe disease, and Cystic Fibrosis are similarly considered.
2025 Grant Recipients
“The 2025 grant awards reflect our unwavering commitment to advancing research in Krabbe disease and Cystic Fibrosis,” said RFRF Executive Director Gabriel M. Cohn, MD, MBA. “Our 2025 grant recipients showcase the broad spectrum of work being done to push the needle forward towards finding effective treatments and improving the lives of patients living with these diseases.”
2025 grant recipients were notified of their award in late 2025, with projects spanning two to three years from the start of funding.
Each full grant application is evaluated by RFRF’s Scientific Advisory Committee (SAC) for alignment with RFRF’s goals and objectives, as well as the proposal’s scientific merit, significance, robustness, and feasibility (scientific, technical, and financial).
Only grant applications that address specific scientific question(s) or applications that address specific educational/awareness goal(s) and that are aligned with RFRF’s mission and vision are funded.
To learn more about this and past year’s grant recipients, visit rosenaufoundation.org/funded-grants.